Communicable Episode 18: The Nightmare Series, part 4 – rubella & polio
Kathryn Hostettler(European Society of Clinical Microbiology and Infectious Diseases), Angela Huttner(University Hospital of Geneva), Bernard Hirschel(University of Geneva), Kerrigan McCarthy(National Health Laboratory Service)
Cited by 0
Related Papers
Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum
|Antimicrobial Resistance and Infection Control|2013|454
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians
|Intensive Care Medicine|2023|293
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
|The Lancet Infectious Diseases|2015|278
Oral amoxicillin and amoxicillin–clavulanic acid: properties, indications and usage
|Clinical Microbiology and Infection|2019|263
Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials
|Journal of Antimicrobial Chemotherapy|2015|262